市場調查報告書

寡核苷酸合成的全球市場的預測

Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2024

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 833820
出版日期 內容資訊 英文 185 Pages
訂單完成後即時交付
價格
Back to Top
寡核苷酸合成的全球市場的預測 Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2024
出版日期: 2019年05月07日內容資訊: 英文 185 Pages
簡介

本報告提供全球寡核苷酸合成市場相關調查分析,市場概要,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第5章 寡核苷酸合成市場:各產品

  • 簡介
  • 合成寡核苷酸
  • 試劑/消耗品
  • 設備

第6章 寡核苷酸合成市場:各用途

  • 簡介
  • 研究
  • 診斷
  • 治療

第7章 寡核苷酸合成市場:各終端用戶

  • 簡介
  • 學術研究機關
  • 製藥、生物科技企業
  • 臨床檢驗室
  • 其他

第8章 寡核苷酸合成市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 競爭情形

  • 競爭基準
  • 市場佔有率分析

第10章 企業簡介

  • Danaher Corporation
  • Merck KGaA (Sigma-Aldrich Co. LLC)
  • Eurofins Genomics LLC (Eurofins Scientific SE的一部分)
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • GE Healthcare
  • GeneDesign Inc. (Ajinomoto的一部分)
  • Kaneka Eurogentec S.A. (KANEKA的一部分)
  • LGC Biosearch Technologies
  • Bio-synthesis Inc.
  • TriLink Biotechnologies LLC (Maravai Lifesciences的一部分)
  • ATDBio Ltd.

第11章 附錄

目錄

Global oligonucleotide synthesis market is expected to reach $2.9 billion by 2024, at a CAGR of 10.5% during the forecast period of 2019 to 2024.

The growth in oligonucleotide synthesis market is mainly attributed to growing adoption of synthesized oligonucleotides in diagnostics and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology companies, plummeting cost of sequencing, increasing public-private spending on genomics, and rising venture capital investments/funding. However, factors such as lack of regulations for commercialization of therapeutic oligos, and price erosion of synthesized oligonucleotides are likely to hinder the market growth. Moreover, emerging Asian markets are likely to provide significant growth opportunities. Also, large-scale synthesis of oligonucleotides, and delivery of oligonucleotide drugs to specific targets are the major challenges for this market.

This study provides a detailed analysis of oligonucleotide synthesis market with respect to various segments on the basis of product, application, end user, and geography. On the basis of product, the global oligonucleotide synthesis market is mainly segmented into synthesized oligonucleotide, reagents, and equipment. The synthesized oligonucleotide segment is further categorized by product, and by type. The synthesized oligonucleotide held the largest share of the global oligonucleotide synthesis market in 2018. The large share of this segment is mainly attributed to the increased adoption and application of synthesized oligonucleotides in research, diagnostics, and therapeutics.

Based on type of application, the global oligonucleotide synthesis market is segmented into three applications: research, diagnostic, and therapeutic. The research application accounted for the largest share of this market in 2018. The major share of research application is mainly attributed to the rising adoption of oligonucleotides in drug discovery & development with the recent development in the gene synthesis and next generation sequencing areas. The large number of oligos are commonly used into various technologies such as PCR, qPCR/RTqPCR, gene synthesis, sequencing, and SNP analysis. However, the diagnostics sector is projected to register the fastest growth during the analysis period owing to the advances in terms of detection methods, particularly with respect to qPCR and sequencing techniques.

Geographically, the global oligonucleotide synthesis market is segmented into five major regions, namely, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America accounted for the major share of the global oligonucleotide synthesis market in 2018, followed by Europe and Asia-Pacific region. The dominating position of North America in the global oligonucleotide synthesis market is mainly attributed to substantial growth in R&D investment; better accessibility & higher adoption of technically advanced products; and the presence of significantly improved infrastructure in biotechnology sector.

The key players operating in the global oligonucleotide synthesis market are Danaher Corporation (U.S.), Merck KGaA (Germany), Eurofins Scientific SE (Europe), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan), Kaneka Eurogentec S.A. (Belgium), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.), and ATD Bio Ltd. (U.K.).

Scope of the Report:

Market by Product

  • Synthesized Oligonucleotides
    • By Product
  • Primers
  • Probes
  • Intermediate-Scale Synthesis Oligonucleotides
  • Large-Scale Synthesis Oligonucleotides
  • Linkers & Adaptors
    • By Type
  • Custom Oligonucleotides
  • Pre-Designed Oligonucleotides
  • Reagents
  • Equipment

Market by Application

  • Research
    • PCR
    • QPCR/RTQPCR
    • Sequencing
    • Gene Synthesis
    • Other Research Applications
  • Diagnostics
  • Therapeutics
    • RNAi
    • Nucleic Acid Aptamers
    • DNA/Antisense Oligonucleotides
    • Immunotherapy Applications

Market by End User

  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Rest of World
    • Latin America
    • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency & Limitation
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Pocesss
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Growing Adoption of Synthesized Oligonucleotides in Diagnostics and Clinical Applications
      • 4.2.1.2. Rising R&D Expenditure and Government Investment in Pharmaceutical and Biotechnology Companies
      • 4.2.1.3. Plummeting Cost of Sequencing
      • 4.2.1.4. Increasing Public-Private Spending on Genomics
      • 4.2.1.5. Rising Venture Capital Investments/Funding
    • 4.2.2. Restraints
      • 4.2.2.1. Lack of Regulations for Therapeutic Oligos
      • 4.2.2.2. Price Erosion of Synthesized Oligonucleotides
    • 4.2.3. Opportunities
      • 4.2.3.1. Emerging Asian Markets
      • 4.2.3.2. Therapeutic Oligos
    • 4.2.4. Challenges
      • 4.2.4.1. Large-Scale Synthesis of Oligonucleotides
      • 4.2.4.2. Delivery of Oligonucleotide Drugs to Specific Targets

5. Oligonucleotide Synthesis Market, by Product

  • 5.1. Introduction
  • 5.2. Synthesized Oligonucleotides
    • 5.2.1. By Product
      • 5.2.1.1. Primers
      • 5.2.1.2. Probes
      • 5.2.1.3. Large-Scale Synthesis Oligonucleotides
      • 5.2.1.4. Intermediate-Scale Synthesis Oligonucleotides
      • 5.2.1.5. Linkers & Adaptors
    • 5.2.2. By Type
      • 5.2.2.1. Custom Oligonucleotides
      • 5.2.2.2. Pre-Designed Oligonucleotides
  • 5.3. Reagents/Consumables
  • 5.4. Equipment

6. Oligonucleotide Synthesis Market, by Application

  • 6.1. Introduction
  • 6.2. Research
    • 6.2.1. PCR
    • 6.2.2. qPCR/RTqPCR
    • 6.2.3. Sequencing
    • 6.2.4. Gene Synthesis
    • 6.2.5. Other Research Applications
  • 6.3. Diagnostics
  • 6.4. Therapeutics
    • 6.4.1. RNAi
    • 6.4.2. Nucleic Acid Aptamers
    • 6.4.3. DNA/Antisense Oligonucleotides
    • 6.4.4. Immunotherapy Applications

7. Oligonucleotide Synthesis Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Research Institutes
  • 7.3. Pharmaceutical and Biotechnology Companies
  • 7.4. Diagnostic Laboratories
  • 7.5. Others

8. Oligonucleotide Synthesis Market, by Geography

  • 8.1. North America
    • 8.1.1. U.S.
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia-Pacific
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4. Rest of the World
    • 8.4.1. Latin America
    • 8.4.2. Middle East & Africa

9. Competitive Landscape

  • 9.1. Competitive Benchmarking
  • 9.2. Market Share Analysis

10. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Danaher Corporation
  • 10.2. Merck KGaA (Sigma-Aldrich Co. LLC)
  • 10.3. Eurofins Genomics LLC (Part of Eurofins Scientific SE)
  • 10.4. Thermo Fisher Scientific, Inc.
  • 10.5. Agilent Technologies, Inc.
  • 10.6. GE Healthcare
  • 10.7. GeneDesign Inc. (Part of Ajinomoto Co., Inc.)
  • 10.8. Kaneka Eurogentec S.A. (Part of Kaneka Corporation)
  • 10.9. LGC Biosearch Technologies
  • 10.10. Bio-synthesis Inc.
  • 10.11. TriLink Biotechnologies LLC (Part of Maravai Lifesciences)
  • 10.12. ATDBio Ltd.

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Available Customization

List of Tables

  • Table 1 Oligonucleotide Synthesis Market Drivers: Impact Analysis (2018-2024)
  • Table 2 Global Oligonucleotide Synthesis Market Restraints: Impact Analysis (2018-2024)
  • Table 3 Global Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 4 Global Synthesized Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
  • Table 5 Global Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 6 Global Primers Market Size, by Country, 2017-2024 ($Million)
  • Table 7 Global Probes Market Size, by Country, 2017-2024 ($Million)
  • Table 8 Global Intermediate Scale Synthesis Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
  • Table 9 Global Large Scale Synthesis Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
  • Table 10 Global Linkers and Adapters Market Size, by Country, 2017-2024 ($Million)
  • Table 11 Global Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 12 Global Custom Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
  • Table 13 Global Pre-Designed Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
  • Table 14 Global Reagents Market Size, by Country, 2017-2024 ($Million)
  • Table 15 Global Equipment Market Size, by Country, 2017-2024 ($Million)
  • Table 16 Global Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 17 Global Oligonucleotide Synthesis Market Size for Research, by Country, 2017-2024 ($Million)
  • Table 18 Global Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 19 Global Oligonucleotide Synthesis Market Size for PCR, by Country, 2017-2024 ($Million)
  • Table 20 Global Oligonucleotide Synthesis Market Size for qPCR/RTqPCR, by Country, 2017-2024 ($Million)
  • Table 21 Global Oligonucleotide Synthesis Market Size for Sequencing, by Country, 2017-2024 ($Million)
  • Table 22 Global Oligonucleotide Synthesis Market Size for Gene Synthesis, by Country, 2017-2024 ($Million)
  • Table 23 Global Oligonucleotide Synthesis Market Size for Other Research Applications, by Country, 2017-2024 ($Million)
  • Table 24 Global Oligonucleotide Synthesis Market Size for Diagnostics, by Country, 2017-2024 ($Million)
  • Table 25 Global Oligonucleotide Synthesis Market Size for Therapeutics, by Country, 2017-2024 ($Million)
  • Table 26 Global Oligonucleotide Synthesis Market Size for Therapeutic, by Type, 2017-2024 ($Million)
  • Table 27 Global Oligonucleotide Synthesis Market Size for RNAi, by Country, 2017-2024 ($Million)
  • Table 28 Global Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamers, by Country, 2017-2024 ($Million)
  • Table 29 Global Oligonucleotide Synthesis Market Size for Antisense Oligonucleotides, by Country, 2017-2024 ($Million)
  • Table 30 Global Oligonucleotide Synthesis Market Size for Immunotherapy Applications, by Country, 2017-2024 ($Thousand)
  • Table 31 Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 32 Global Oligonucleotide Synthesis Market Size for Academic Research Institutes, by Country, 2017-2024 ($Million)
  • Table 33 Global Oligonucleotides Synthesis Market Size for Pharmaceutical and Biotechnology Companies, by Country, 2017-2024 ($Million)
  • Table 34 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, by Country, 2017-2024 ($Million)
  • Table 35 Global Oligonucleotide Synthesis Market Size for Other End Users, by Country, 2017-2024 ($Million)
  • Table 36 Global Oligonucleotide Synthesis Market Size, by Geography, 2017-2024 ($Million)
  • Table 37 North America: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
  • Table 38 North America: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 39 North America: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 40 North America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 41 North America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 42 North America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 43 North America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 44 North America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 45 U.S.: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 46 U.S.: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 47 U.S.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 48 U.S.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 49 U.S.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 50 U.S.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 51 U.S.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 52 Canada: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 53 Canada: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 54 Canada: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 55 Canada: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 56 Canada: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 57 Canada: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 58 Canada: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 59 Europe: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
  • Table 60 Europe: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 61 Europe: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 62 Europe: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 63 Europe: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 64 Europe: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 65 Europe: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 66 Europe: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 67 Germany: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 68 Germany: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 69 Germany: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 70 Germany: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 71 Germany: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 72 Germany: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 73 Germany: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 74 France: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 75 France: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 76 France: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 77 France: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 78 France: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 79 France: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 80 France: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 81 U.K.: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 82 U.K.: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 83 U.K.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 84 U.K.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 85 U.K.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 86 U.K.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 87 U.K.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 88 Italy: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 89 Italy: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 90 Italy: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 91 Italy: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 92 Italy: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 93 Italy: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 94 Italy: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 95 Spain: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 96 Spain: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 97 Spain: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 98 Spain: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 99 Spain: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 100 Spain: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 101 Spain: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 102 RoE: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 103 RoE: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 104 RoE: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 105 RoE: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 106 RoE: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 107 RoE: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 108 RoE: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 109 APAC: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
  • Table 110 APAC: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 111 APAC: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 112 APAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 113 APAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 114 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 115 APAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 116 APAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 117 China: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 118 China: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 119 China: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 120 China: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 121 China: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 122 China: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 123 China: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 124 Japan: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 125 Japan: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 126 Japan: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 127 Japan: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 128 Japan: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 129 Japan: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 130 Japan: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 131 India: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 132 India: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 133 India: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 134 India: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 135 India: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 136 India: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 137 India: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 138 RoAPAC: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 139 RoAPAC: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 140 RoAPAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 141 RoAPAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 142 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 143 RoAPAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 144 RoAPAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 145 RoW: Oligonucleotide Synthesis Market Size, by Region, 2017-2024 ($Million)
  • Table 146 RoW: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 147 RoW: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 148 RoW: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 149 RoW: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 150 RoW: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 151 RoW: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 152 RoW: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 153 Latin America: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 154 Latin America: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 155 Latin America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 156 Latin America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 157 Latin America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 158 Latin America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 159 Latin America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 160 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
  • Table 161 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
  • Table 162 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
  • Table 163 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
  • Table 164 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
  • Table 165 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
  • Table 166 Middle East & Africa: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
  • Table 167 Number of Developments by the Major Players during 2015-2018
  • Table 168 Key Products: Synthesized Oligonucleotides

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Opportunities
  • Figure 5 Oligonucleotide Synthesis Market, by Product
  • Figure 6 Oligonucleotide Synthesis Market, by Application
  • Figure 7 Oligonucleotide Synthesis Market, by End User
  • Figure 8 Oligonucleotide Synthesis Market, by Region
  • Figure 9 Market Dynamics
  • Figure 10 Share of Medical and Health R&D Expenditure of U.S., by Type of Organization: 2015
  • Figure 11 Global Oligonucleotide Synthesis Market Size, by Product, 2019-2024 ($Million)
  • Figure 12 Global Synthesized Oligonucleotides Market Size, by Product, 2019-2024 ($Million)
  • Figure 13 Global Synthesized Oligonucleotides Market Size, by Type, 2019-2024 ($Million)
  • Figure 14 Global Oligonucleotide Synthesis Market Size, by Application, 2019-2024 ($Million)
  • Figure 15 Global Oligonucleotide Synthesis Market Size, by End User, 2019-2024 ($Million)
  • Figure 16 Pharmaceutical R&D Spending, 2011-2017
  • Figure 17 Global Oligonucleotide Synthesis Market Size, by Geography, 2019-2024 ($Million)
  • Figure 18 North America: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
  • Figure 19 Number of People with Chronic Diseases in America: 2005-2030 (Million)
  • Figure 20 Number of People Aged 60 Years & Above in Europe, in 2017 Vs 2050 (In Million)
  • Figure 21 Europe: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
  • Figure 22 Number of Biotech Companies With Business Segments, 2017
  • Figure 23 Spain: Proportion of Overweight Population (In %), 2000-2020
  • Figure 24 Spain: Life Expectancy Compared To European Union, 2000-2015
  • Figure 25 Proportion of Elderly Population in Poland, 2000-2030 (%)
  • Figure 26 APAC: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
  • Figure 27 Share of Non-Communicable Diseases in Total Death in China, 2005-2020 (%)
  • Figure 28 Japan: % of Population Aged 65 Years & Above, 1950-2050 (%)
  • Figure 29 RoW: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
  • Figure 30 Growth Strategies Adopted by the Key Players between 2015 and 2018
  • Figure 31 Oligonucleotide Synthesis Market: Competitive Benchmarking
  • Figure 32 Danaher Corporation: Financial Overview-2015-2017
  • Figure 33 Merck KGaA: Financial Overview-2015-2017
  • Figure 34 Eurofins Scientific: Financial Overview-2016-2018
  • Figure 35 Thermo Fisher Scientific Inc.: Financial Overview-2015-2017
  • Figure 36 Agilent Technologies, Inc.: Financial Overview-2015-2017
  • Figure 37 GE Healthcare: Financial Overview-2015-2017
  • Figure 38 Ajinomoto Co., Inc.: Financial Overview-2016-2018
  • Figure 39 Kaneka Corporation: Financial Overview-2016-2018
Back to Top